Olema Pharmaceuticals, Inc.
OLMA
$10.63
$0.121.14%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -63.20M | -53.09M | -46.06M | -42.22M | -43.78M |
| Total Depreciation and Amortization | 102.00K | 119.00K | 187.00K | 43.00K | 132.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.98M | 9.18M | 3.41M | 3.23M | 3.27M |
| Change in Net Operating Assets | 5.22M | -2.19M | 4.14M | 4.42M | 10.50M |
| Cash from Operations | -45.90M | -45.99M | -38.33M | -34.53M | -29.88M |
| Capital Expenditure | -221.00K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 41.06M | 4.53M | -162.18M | 17.27M | 34.23M |
| Cash from Investing | 40.84M | 4.53M | -162.18M | 17.27M | 34.23M |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 3.00M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.41M | 50.37M | 226.66M | 41.00K | 982.00K |
| Repurchase of Common Stock | -3.54M | -4.41M | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 237.00K | -262.00K | -13.11M | 0.00 | -6.50M |
| Cash from Financing | 1.11M | 45.70M | 213.55M | 41.00K | -2.52M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.95M | 4.25M | 13.04M | -17.21M | 1.83M |